@Semos25 Omada Health [US68170A1088] Morgan Stanley rates the share as a top recommendation - price target USD 32 (122% upside potential) The company is a provider of digital programs for the care of people with chronic diseases. The focus is on completely virtual care that combines medical professionals, personal coaches, app-based tools and networked health devices. Users receive personalized treatment plans, regular support and data-driven recommendations.
